April 11, 2025

Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

In ER-low, early-stage BC, ET omission is associated with significantly worse OS, especially in patients with RD after NAC and those with higher (6%-10%) ER levels. Until prospective data are available, patients with ER-low BC should be counseled regarding the potential benefit of ET.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Choong et al. (Fri,) studied this question.

www.synapsesocial.com/papers/69d8e8a62c39562886ae3255 — DOI: https://doi.org/10.1200/jco-24-02263

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Authors

Grace M. Choong

Tanya L. Hoskin

Judy C. Boughey

Journals

Journal of Clinical Oncology

Actions

Institutions

Mayo Clinic

Mayo Clinic in Arizona

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion